These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 1525787

  • 1. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH, Estrella ME, Muñoz M.
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [Abstract] [Full Text] [Related]

  • 2. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
    Sánchez S, Luna A, Orozco R, Velasco G.
    Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
    [Abstract] [Full Text] [Related]

  • 3. Effects of quinapril and verapamil versus atenolol on blood pressure during dynamic leg exercise.
    Cléroux J, Beaulieu M, Lemieux SC, Lacourcière Y.
    J Hypertens Suppl; 1993 Dec; 11(5):S370-1. PubMed ID: 8158427
    [No Abstract] [Full Text] [Related]

  • 4. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H, Mimran A, Zanchetti A, Creytens G, Rorive G, Brown CL, Santoni JP.
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [Abstract] [Full Text] [Related]

  • 5. A study of the effects of lisinopril when used in addition to atenolol.
    Soininen K, Gerlin-Piira L, Suihkonen J, Kyllönen T, Parviainen R, Kyllönen E, Hämäläinen K, Lonka R, Tikkanen T, Selonen R.
    J Hum Hypertens; 1992 Aug; 6(4):321-4. PubMed ID: 1331443
    [Abstract] [Full Text] [Related]

  • 6. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 7. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension.
    Weir MR.
    J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504
    [Abstract] [Full Text] [Related]

  • 8. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA, Chang SM, Chou TC.
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
    Hausberg M, Barenbrock M, Hohage H, Müller S, Heidenreich S, Rahn KH.
    Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
    [Abstract] [Full Text] [Related]

  • 11. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991 Mar; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [Abstract] [Full Text] [Related]

  • 12. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
    Lacourcière Y, Lefebvre J, Provencher P, Poirier L.
    Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
    [Abstract] [Full Text] [Related]

  • 13. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P, Haynes B, Maron N, Dugas S.
    Clin Ther; 1994 Feb; 16(5):838-53. PubMed ID: 7859244
    [Abstract] [Full Text] [Related]

  • 14. Hypotensive effects and influence on serum lipids of SQ29,852, a new angiotensin converting enzyme inhibitor, in patients with essential hypertension: a comparison with atenolol.
    Sasaki J, Koga S, Kato K, Takii M, Sakai K, Kawasaki K, Kagimoto M, Doi Y, Takada K, Sakaue A.
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):83-8. PubMed ID: 8458681
    [Abstract] [Full Text] [Related]

  • 15. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O, Rydén L.
    Acta Med Scand; 1981 Feb; 209(4):261-6. PubMed ID: 7015797
    [Abstract] [Full Text] [Related]

  • 16. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 17. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension.
    Islim IF, Bareford D, Beevers DG.
    Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379
    [Abstract] [Full Text] [Related]

  • 18. Quinapril in the treatment of hypertension in primary care centers.
    Alcocer L, Novoa G, Sotres D.
    Clin Ther; 1993 Aug; 15(6):1021-30. PubMed ID: 8111799
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B, Keller SE, Makris L, Goldberg AI, Sweet CS, Lim NY.
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [Abstract] [Full Text] [Related]

  • 20. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
    Maclean D.
    Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.